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ABSTRACT 
Introduction  
Data about congenital heart disease, in particular aortic stenosis, remains scarce from the 
African continent. Aortic stenosis can be supravalvular, valvular or subvalvular. Anecdotal 
evidence in our setting suggested that the aortic stenosis subtype profile differed to that of 
western literature. A retrospective record review of all children presenting to Chris Hani 
Baragwanath Academic Hospital with aortic stenosis from 1984 to June 2015 was undertaken. 
Results 
The majority of the patients 76% (n=205), presented with subvalvular aortic stenosis. Boy and 
girl children were almost equally effected. The echocardiographical peak instantaneous 
gradient measured across the stenotic left ventricular outlet obstruction varied depending on 
the level of stenosis. The majority of subvalvular aortic stenoses 123 (62%) presented with 
mild peak instantaneous gradients (p<0.005) at presentation, most likely due to its copresence 
with ventricular septal defects. Furthermore, the majority of children with subvalvular aortic 
stenosis presented with co-existing cardiac lesions. Consequently, the majority of patients with 
discrete subaortic stenosis (n=116, 61%) required surgical intervention. 
Conclusion 
DSAS was highlighted as the predominant aortic stenosis subtype in this population. This is 
different to western literature where valvular aortic stenosis is most common. Boys were not 
found to be significantly more affected than girls, as reported in other countries. The majority 
of patients had associated cardiac lesions, and most of which required invasive surgical 
treatment. 
Key words 
Congenital cardiac lesions, aortic stenosis, valvular, subvalvular, peak instantaneous gradient, 
isolated discrete subvalvular stenosis. 
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RESEARCH PROTOCOL 
 
1. INTRODUCTION  
This report focuses on the incidence, characteristics and outcomes of patients with aortic 
stenosis at Chris Hani Baragwanath Academic Hospital (CHBAH) over the past two decades. 
Aortic stenosis can be congenital or acquired and may be associated with known genetic 
disorders.  
 
Left ventricular outflow tract obstruction (LVOTO) including aortic stenosis occurs in 
approximately six per cent of children with heart disease.1,2 Aortic stenosis is a complex 
anomaly with various levels of possible obstruction of the left ventricular outflow tract, which 
may occur at the valve (valvular), below the valve (subvalvular) and above the valve 
(supravalvular). The most common type reported worldwide is valvular aortic stenosis.1 The 
most frequent type that has been recorded on the paediatric cardiology database at CHBAH is 
the subvalvular type which has a different aetiology and genetic substrate to the valvular type. 
These differences could be related to ethnicity of the population of children treated at our 
institution, who may have less of a predisposition to the valvular type but have a greater 
susceptibility to the subvalvular type. Subvalvular AS has been described to be the least 
common AS subtype in the Chinese population, possibly showing the influence of population 
type.3 The paucity of data from the rest of Africa regarding prevalence of the various types of 
aortic stenosis allows for a unique opportunity to provide the first such profile from the 
continent.  
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2. BACKGROUND 
The burden of congenital heart disease falls most heavily on countries with the lowest incomes 
and the highest fertility rates.4 
 
The crude incidence rate of congenital heart anomalies is approximately 8.8 per 1000 live 
births.5 The reported —Data from the European Surveillance of Congenital Anomalies central 
database for 29 population-based congenital anomaly registries in 16 European countries 
covering 3.3 million births during the period 2000 to 2005 also reported the total prevalence of 
CHD in Europe was 8.0 per 1000 births (95% CI 7.9 to 8.1).6 
 
Globally, it is estimated that six percent of all congenital heart defects in children are left 
ventricular outflow tract obstruction.5 This includes constriction somewhere at the level of the 
aortic valve. The most prevalent stenosis is encountered at the level of the valve (71%), then 
subvalvular stenosis (23%) and supravalvular stenosis (6%).7 Though literature from China 
reported that amongst their paediatric population group, subvalvular AS and not supravalvular 
AS was the least common type.3 
 
2.1. Aortic Stenosis – Theory  
There are various anatomical constrictions which make up the gamut of AS: 
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2.1.1. Valvular aortic stenosis 
Eighty-five per cent of stenotic aortic valves are bicuspid, and fourteen per cent have no 
separation of the leaflets.8 Aortic stenosis that is congenital may be progressive. Children 
usually present soon after birth with an ejection systolic murmur. Newborn infants with critical 
stenosis of the aortic valve may develop signs of hypoperfusion or respiratory distress related 
to pulmonary edema within days to weeks after birth.7 
 
However, older children with mild to moderate AS may present later in life with syncopal 
attacks or chest pain. These symptoms are indications for treatment as is pressure gradients 
greater than 70 mmHg on echocardiogram.8 The treatment of choice includes surgical or 
balloon valvuloplasty. 
 
2.1.2. Bicuspid aortic valve 
It occurs in approximately 1 to 2% of the population. It is important as the patient may go onto 
develop a stenotic valve later on in life, but this complication is only seen in patients that are 
over 40 years of age.8 
 
2.1.3. Discrete Subvalvular Aortic Stenosis 
Discrete Subvalvular Aortic Stenosis (DSAS) is a thin membranous diaphragm or a thick 
fibromuscular obstruction. It may be encountered in isolation or associated with other 
congenital cardiac abnormalities. DSAS occurs in 5% of children with heart disease, and 
constitutes 20% of LVOTO in children in the western literature.2 DSAS may not be present at 
birth but develop over time and therefore continuously progress in severity, and despite 
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management it may recur with time. One hypothesis is that an underlying abnormality in left 
ventricular outflow tract (LVOT) architecture creates turbulence, which then contributes to 
progressive LVOT thickening, fibrosis, and scarring, with scarring.9 
 
2.1.4. Diffuse Subaortic Stenosis 
This is associated with any diffuse hypertrophy of the left ventricle. The most common cause 
is idiopathic.8 
 
2.1.5. Supravalvular Aortic Stenosis 
It may be a localized or diffuse narrowing just superior to the level of the coronary arteries. 
Therefore with this anatomical aberration coronary perfusion may be affected.8 Supravalvular 
Aortic Stenosis may occur in isolation but it is associated with Williams syndrome.8 
 
Aortic stenosis almost always coexists with a second cardiac malformation or anomaly.10 The 
most common defect is the patent ductus arteriosus (34%), ventricular septal defect (20%), 
aortic coarctation (23%), pulmonic stenosis (9%), and other lesions (14%).10  
 
2.2. Aortic Stenosis – Epidemiology  
The most common type of aortic stenosis reported worldwide is valvular aortic stenosis.1 
However, at CHBAH the most frequent type appears to be the subvalvular type, which has a 
different aetiology and genetic substrate to the valvular type. These differences could be related 
to ethnicity of the population of children treated at the CHBAH. A study by Chandra et al 
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demonstrated inter-racial differences of aortic dimension and frequency in adult patients with 
bicuspid aortic valves.11 Aortic stenosis both valvular and subvalvular is seen more commonly 
in males (75%),12 contrary to other cardiac congenital abnormalities in which females are the 
majority of patients.4 In 2000, females accounted for 52% and 57% of the CHD population in 
children and adults, respectively.13       
 
The reasons for the greater susceptibility to the subvalvular type in the CHBAH are not clearly 
understood. Therefore confirming this variance may translate into managing AS patients in 
South Africa differently than is described globally. The paucity of data from Africa describing 
the prevalence of the various types of aortic stenosis allows for a unique opportunity to provide 
the first such profile from the continent. 
 
3. AIM AND OBJECTIVES 
3.1.  Main Aim 
The description of the paediatric population with AS presenting to the Department of Paediatric 
Cardiology at Chris Hani Baragwanath Academic Hospital from the 1984 to 2015. 
 
3.2. Specific Objectives 
 
3.2.1. Describe the types and proportions of all cardiac lesions in the Paediatric 
Cardiology database (PdA),  
3.2.2. Describe the paediatric patients with AS on the PdA, including the subset of 
patients with isolated DSAS, 
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3.2.3. Describe the echocardiography and cardiac catherisation findings of the AS 
lesions.  
 
4. METHODOLOGY 
Various demographic and surgically related parameters of patients with AS were extracted 
from a computerized database and clinic files. 
 
4.1. Study Design 
A retrospective record review will be undertaken and descriptive analysis will be completed. 
No intervention will be undertaken during this study. 
 
4.2. Study Setting 
Chris Hani Baragwanath Academic Hospital (CHBAH) is located in Soweto, in the south of 
Johannesburg, Gauteng. It is one of forty hospitals in the province. CHBAH was reported to 
be the third largest hospital in the world, with approximately 3 200 beds.  It is a teaching 
hospital for the University of the Witwatersrand Medical School. It offers medical care for 
children in a large catchment area, and is the referral centre for neighbouring provinces.14 
 
4.3. Study Population 
The population will include all paediatric patients that have sought medical management at the 
Chris Hani Baragwanath paediatric cardiology unit during the study period. 
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4.4. Study Period 
The study period will extend from January 1984 to the 30 June 2015.  
 
4.5. Data Management 
4.5.1.  Data Collection and Capture 
The principal researcher will be responsible for the collection, capture and collation of data. 
Nominal data may be categorised and coded for analysis. Where appropriate numerical data 
will be categorised and coded. 
 
Patient information will be extracted from two sources: 
1. The Paediatric Cardiology Database for South Africa  
The Paediatric Cardiology Database for South Africa (“PdA”) was initiated by Professor 
Antoinette Cilliers in 1984. In which every patient attended by a physician in the Department 
of Paediatric Cardiology at CHBAH, both in-patient and outpatient, is entered. This has led to 
a database that is rich in patient information (demographic details, echocardiographic 
recordings, diagnoses, complementary investigations and follow up). This database has been 
entered into a Microsoft Office Access software package. The gatekeeper of the paediatric 
cardiology database is Professor Antoinette Cilliers, co-researcher on this study.  
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2. Patient Cardiology Files 
In the event data are missing from the PdA, or more information is required, patients’ 
cardiology files will be accessed. The patient forename, surname and hospital number will be 
used to identify the patient from the patient in the PdA. 
 
Study Tools  
The study tool was developed in Microsoft Office Excel 2003 (Tool I). Please see appendix. 
 
4.5.2. Study Variables 
The variables available for analyses from the PDA-database included (Table 4.1): 
 The number of paediatric patients with AS 
 The demographic details of the paediatric patients with AS 
 The cardiac defects associated with AS 
 The description of a subset of patients with isolated DSAS. 
 The description of peak and mean pressure gradients across the LVOT (recorded from 
echocardiography and cardiac catheterisation) 
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Table 4.1: List of variables by objective:  
Objective 1: Congenital cardiac lesions: VSD, ASD, PDA, coarctation of 
the aorta 
Objective 2:  Province, age, sex, type of AS, associated cardiac lesions, 
co-morbidities if any, syndromes. 
Objective 3: 
Echocardiography: anatomical presentation of AS 
(supravalvular, valvular, subvalvular), doppler findings      
(PIG (mmHg) across LVOT), aortic regurgitation (AR), 
Cardiac catheterisation: PIGs (mmHg) across LVOT 
 
4.5.3. Statistical Analyses 
Stata release 10.0 (StataCorp LP), for Microsoft Windows, was the preferred software for 
analyses. The descriptive analyses reported proportions and percentages. Central tendency and 
data dispersion will be described in normally distributed data using mean and standard 
deviation (±SD), and in non-normally distributed data, median and inter-quartile range (IQR) 
respectively.  
 
Table 4.2: Univariate analyses of data and relevant variables 
Descriptive 
analyses 
Variable  Distribution  Description  Variables  
Univariate  Categorical  Percentages 
 
Type of cardiac 
lesions, AS subtype, 
sex, province, cardiac 
lesions, syndromes,AR 
 Continuous  Non-normal Median (IQR) Age, PIG  
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Bivariate analyses will be undertaken to determine correlations and associations - One-way 
ANOVA, Pearson Chi-Square tests, Fisher Exact test will be utilised depending on the type 
and number of data analysed.  
 
Table 4.3: Bivariate analyses of data and relevant variables 
Analytical 
analyses 
Dependent 
variable 
Distribution Statistical test Variables 
 
Bivariate  Categorical 
 
Chi-distribution Pearson  
Chi-square Test 
Type of AS, AR 
sex, province, 
cardiac defects 
   Fisher’s Exact Test Type of AS, AR 
sex, syndromes 
cardiac defects 
 Continuous  Non-normal Mann-Whitney 
Test, 
Wilcox Rank-sum 
Test 
Age, PIG 
  Normal One-way ANOVA Age, PIG 
 
4.5.4. Study Instrument  
The study tool will encompass an excel spreadsheet developed on Microsoft Office. The 
patient’s name will remain confidential with the development of a study number as an 
identifier. There will be a reference chart, which will have the patient’s name and the patient’s 
hospital number. The principle researcher will only have access to this reference chart. 
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5. ETHICS APPRAISAL 
The study was approved by the University of the Witwatersrand Human Research Ethics 
Committee, M150848. 
 
6. TIMEFRAMES OF THE STUDY 
The overall timeframe of the study will be span from August 2015 to June 2017 (Table 6.1). 
Table 6.1: Study Timeframes 
Deliverable Date 
Ethics Appraisal  August 2015 
PDA data collection September 2015 
Record review  November 2016 
Analysis & draft report  December 2016 
Final report January 2017 
Submit manuscript for publication  June 2017 
 
7. LIMITATIONS 
The findings are strongly reliant on the completeness and availability of patients’ cardiology 
files and the PdA. 
 
8. BUDGET REQUIREMENTS 
The budgetary requirements will be the responsibility of the researcher. No expenses are 
anticipated. 
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SUBMISSIBLE REPORT 
INTRODUCTION 
 
The burden of congenital heart disease weighs most heavily on countries with the lowest 
incomes and the highest fertility rates.1 
 
The crude incidence rate of congenital heart anomalies reported in the USA is approximately 
8.8 per 1000 live births,2 with a similar prevalence reported in European countries at 
approximately 8.0 per 1000 live births.3 In South Africa the estimated prevalence is 
approximately 0.6 – 0.8 per 1000 live births, which translates into an estimated 11000 children 
annually, of which 4500 may require surgical intervention.4 
 
Left ventricular outflow tract obstruction (LVOTO) refers to congenital heart disease, 
presenting as a stenotic area in the anatomical left ventricular outflow tract (LVOT) or in the 
descending part of the aortic arch, including the aortic valve. In the paediatric population, 
hypoplastic left heart syndrome and coarctation of the aorta are also considered in the gamut 
of LVOTO.5,6 Congenital LVOTO commonly occurs with other cardiac defects and is rarely 
identified alone.6 
 
Aortic stenosis (AS), a LVOTO, is clinically relevant in our setting, as children can present at 
any age depending on the type and severity of the AS. Newborn infants with critical aortic 
stenosis may develop signs of hypoperfusion or respiratory distress, secondary  to pulmonary 
oedema within days to weeks after birth.7 Other patients may present later in life with syncope, 
and effort intolerance with or without features of left ventricular hypertrophy and cardiac 
failure.5 
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AS contributes to  approximately 3 percent of all congenital cardiac defects.8 A male to female 
preponderance of 4:1 is documented in the literature.7,8 
There are three levels of stenosis viz. above the aortic valve or supravalvular AS, at the level 
of the valve or valvular stenosis and below the aortic valve or subvalvular stenosis. Subvalvular 
stenosis (SAS) may be a fixed membranous type of narrowing, described as a discrete 
subvalvular stenosis (DSAS), or it may be a variable muscular tunnel-type form (TSAS).6 
 
The most common subtype of AS reported in the international literature is valvular stenosis 
(71%), followed by subvalvular stenosis (23%) and supravalvular stenosis (6%).7,9 Contrary to 
mainstream literature, a study from China reported that subvalvular AS and not supravalvular 
AS was the least common subtype identified in their paediatric population.10 It appeared that 
AS subtype prevalence could differ amongst population groups. 
 
1. Supravalvular Aortic Stenosis 
Supravalvular AS is the least common type of AS.8 It is an annular stenosis above the aortic 
valve7 and  is commonly found in patients with Williams syndrome (elfin features, mental 
retardation and peripheral pulmonary stenosis).8,11 The main histological feature in 
supravalvular AS is the reduction  and disorganization of elastin fibres within the aortic            
media.12 
 
Surgical intervention is recommended once the patient is symptomatic or has a mean pressure 
gradient greater than 50 mm Hg.  
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2. Valvular Aortic Stenosis 
Valvular AS imposes its restriction at the level of the aortic valve.8  The stenotic valve can be 
unicuspid, bicuspid or tricuspid.8 Valvular stenosis can cause symptoms in infancy, and is 
associated with a high mortality rate.13 In the newborn period critical AS can occur presenting 
with left ventricular insufficiency, requiring emergency intervention by means of balloon 
angioplasty or surgical valvotomy.14-16 A peak pressure gradient, greater than 70 mmHg on 
echocardiogram without symptoms, or symptoms of syncope or chest pain in older children are 
indications for treatment.17 The treatment of choice includes surgical or balloon valvuloplasty. 
 
3. Subvalvular Aortic Stenosis 
a) Discrete Subvalvular Aortic Stenosis 
Discrete subvalvular aortic stenosis (DSAS) is a thin membranous diaphragm, encountered in 
isolation or associated with other congenital cardiac abnormalities. DSAS occurs in 5% of 
children with heart disease constituting 20% of LVOTO in children in the western literature.18 
DSAS is commonly found in association with other congenital cardiac defects, such as patent 
ductus arteriosus and ventricular septal defects. A few reports have identified tetralogy of Fallot 
as a rare association in children with DSAS.19,20 
 
The aetiology of DSAS is speculative. One hypothesis is that a reduced left ventricular aortic 
angle creates turbulence, which then contributes to progressive LVOT thickening, fibrosis and 
scarring. The jet across the stenotic membrane can damage the previously normal aortic valve 
resulting in aortic regurgitation.21,22 The supposition that fixed SAS is an acquired lesion is 
supported by proof of its gradual development, its progressive nature and its rarity in infants.23 
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DSAS is unpredictable; and despite excision it may recur.23,24 Approximately 16-46% recur 
after initial surgical intervention, especially in patients with complex lesions.25 Recurrence is 
generally associated with high peak instantaneous gradients.20,26 A mean gradient derived 
echocardiographically, in excess of 50 mmHg has been linked to recurrence and poor 
outcomes. The turbulent jet created by the DSAS may cause  damage to the aortic valve which 
is downstream from the discrete stenosis.27 Early removal of fixed DSAS has been shown to 
be beneficial in preventing damage occurring to the aortic valve.28 
 
b) Tunnel-type Subvalvular Aortic Stenosis (TSAS) 
TSAS is any diffuse, long, tunnel-like narrowing of the left ventricle, frequently associated 
with other congenital heart lesions.25 
 
Aortic stenosis and its various levels of involvement require different treatment approaches.  
Aortic valvular stenosis is the most frequent subtype, followed by DSAS reported in the 
western world, DSAS has been described least commonly in China; however anecdotally it 
was our population’s most common AS subtype.  The treatment of DSAS is more invasive, 
requiring open heart surgery as opposed to valvular AS which can be treated with percutaneous 
balloon valvuloplasty. Open heart surgery is a technically demanding and expensive 
therapeutic intervention which can be limiting in a resource constrained setting. Despite the 
asymptomatic child having a good outlook even with severe obstruction, those with symptoms 
may have mortality rates as high as 25% per year, making timeous management essential.29 
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Furthermore, interventions directed toward relief of AS should be considered as palliative 
rather than curative, the susceptibility of recurrence mandates lifelong patient follow-up, and 
many of our paediatric cardiology patients come from other parts of Gauteng, other provinces 
and neighbouring countries, which  makes necessary follow-up challenging.13 
 
A comprehensive review of the literature has not identified any previous publications detailing 
the clinical profile of children with aortic stenosis in an African setting. 
 
 
 
 
 23 
 
METHODOLOGY 
 
A retrospective record review of children with aortic stenosis was undertaken using a 
computerized electronic database (see below for the list of variables and Appendix C), which 
documented information, concerning every patient presenting to the Paediatric Cardiology 
clinic at the Chris Hani Baragwanath Academic Hospital (CHBAH) over more than two 
decades from 1984 to June 2015. CHBAH is a tertiary/quaternary hospital, with approximately 
3 200 beds, it is situated in the townships of Soweto (population of 1.1 million) in 
Johannesburg, South Africa.14 The computerized electronic database known as the Paediatric 
Cardiology Database for South Africa (“PdA”), utilises Microsoft Office Access Software, and 
was commenced in 1984. It records demographic details, echocardiographic recordings, 
diagnoses, complementary investigations and follow up. Additional or missing data, were 
sourced from cardiac clinic patient records.  
 
The mean instantaneous gradient across the valve stenosis was not consistently documented 
for each patient; therefore the peak instantaneous gradient (PIG) acquired using 
echocardiography was reported instead. The PIG measured across the AS  was categorized into 
ordinal categories:30 
 Mild PIG (0-20 mmHg) 
 Moderate PIG (21-50 mmHg) 
 Severe PIG (> 50 mmHg) 
 
Descriptive and limited comparative analyses were completed using various demographic and 
clinical related parameters of the children with AS.   
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Statistical Analysis 
Stata release 10.0 (StataCorp LP), for Microsoft Windows, was the preferred software tool for 
analyses. The descriptive analyses reported proportions and percentages. Central tendency and 
data dispersion were described in non-normally distributed data, by median and inter-quartile 
range (IQR). A value of p < 0.05 was considered statistically significant. Bivariate analyses 
were undertaken to determine any statistically significant patient differences or similarities 
between the AS subtypes and within the SAS subtype (age, sex, presence of cardiac defects, 
PIG, recurrence, aortic regurgitation) - Pearson Chi-square test, and Fisher’s exact test was 
utilized for categorical data, depending on sample numbers. Mann-Whitney U-test and 
Kruskal-Wallis H-tests were performed for non-parametric data, depending on the number of 
comparative groups; in more than two groups the latter test was used. A regression model was 
used to determine any significant predictors in the isolated DSAS compared to the DSAS group 
associated with cardiac defects cardiac defects. The covariates identified during the univariate 
analysis at the 10% significant level were used in the model, peak instantaneous gradient and 
aortic regurgitation were run in the model. 
Loss to Follow up  
The patients lost to follow up, were defined as those patients that missed follow up 
appointments consecutively. The study period ranges more than two decades, this made 
verifying the causes for missed appointment less clear.  
 Ethics Approval 
The study was approved by the University of the Witwatersrand Human Research Ethics 
Committee, M150848.  
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RESULTS 
 
The “PdA” Population 
The total number of patients documented on the PdA during the study period was 22 669. The 
majority of patients were registered with a Soweto residential address and at least one-third of 
patients reported residential addresses from neighbouring referral provinces. 
 
Congenital Heart Defects 
Forty-two percent (n=9408) were diagnosed with a congenital cardiac defect, of which 77% 
(n=7272) were acyanotic anomalies (Table 1). The two most common congenital defects 
identified were patent ductus arteriosus in 28% (n=2676) and ventricular septal defects in 22% 
(n=2102). Tetralogy of Fallot (TOF) was the most common cyanotic defect (5%).  
Table 1: List of congenital heart defects subdivided by acyanotic and cyanotic lesions 
(Total N = 9408) (PdA; 1984 - 2015) 
Acyanotic Congenital   
Heart Defects 
n (%) Cyanotic Congenital 
Heart Defects 
n (%) 
Patent ductus arteriosus 2676 (28%) Tetralogy of Fallot 493 (5%) 
Ventricular septal defects 2102 (22%) Pulmonary atresia 152  (2%) 
Peripheral pulmonary stenosis 756 (8%) Tricuspid atresia  142 (2%) 
Atrio-ventricular septal 
defects 
649 (7%)   Transposition of the great 
vessels 
127 (1%) 
Pulmonary valve stenosis 445 (5% ) Other 1222 (13%) 
Other  644 (7%)    
Total  7272 (77%) Total  2136 (23%) 
 
Left ventricular outflow tract obstructive lesions comprised 8% (n/N=722/9408) of all 
congenital heart defects. Aortic stenosis was identified in 268 children, 37% of LVOTO and 
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3% of all congenital cardiac defects. The median age of presentation for children with AS was 
17 months (IQR; 3-57). Fifty-five percent (n=149) were male children.  
 
Aortic Stenosis Subtypes  
Four percent (n=11) of AS were supravalvular, 17% (n=47) were valvular and 76% (n=205) 
were subvalvular (DSAS and TSAS). Two percent (n=5) of children presented with both 
subvalvular and valvular stenoses. These five children were excluded from the analyses. 
 
Seventy-two percent and 77% of children with supravalvular and valvular AS respectively,  
reported residential addresses from outside the  province of Gauteng compared to 32% of 
patients with subvalvular AS, though this was substantial it was not significant (Fisher’s exact; 
p=0.13) (Table 2).  Children with valvular AS, had a tendency to present at a younger median 
age 4 months (IQR; 0.3-76) compared to those children with subvalvular AS and supravalvular 
AS which presented at 19 months (IQR; 4-17) and 46 months (IQR; 8-92) respectively (Kruskal 
Wallis; p=0.07). Males constituted the larger proportion of supravalvular lesions (72%), and 
half of the other two subtypes, but it was not significant, possibly influenced by the small 
sample size (Fisher’s exact; p=0.07) (Table 2). 
 
The majority (86%) of subvalvular AS lesions co-existed with cardiac defects, and hence only 
28 (14%) were found in isolation, conversely, significantly more isolated lesions (n=25; 53%) 
were found with valvular AS and supravalvular AS (n=4; 36%) (Fisher’s exact; p<0.05).  
 
The PIG differed significantly between the AS subtypes, a lower number (n=75/119; 38%) of 
the children with subvalvular AS presented with moderate or severe PIG, in contrast, to the 
higher number of those with supravalvular (n=9/10; 90%) and valvular AS subtypes (n=32/39; 
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82%) which had moderate or severe PIGs (Fisher’s exact; p<0.05) (Table 2). One-half (53%) 
of children required surgical intervention to relieve the aortic stenosis (all types) more 
frequently than balloon valvuloplasties (Pearson χ2; p<0.05) (Table 2). 
 
Table 2: The demographic and clinical profile of children with aortic stenosis by 
subtype (PdA; 1984 - 2015) 
Demographic & Clinical details Supravalvular 
(N = 11) 
Valvular 
(N = 47) 
Subvalvular 
(N = 205 ) 
p-value 
Age (months) median 
(IQR) 
46 
(8-92) 
4 
(0.3-76) 
19 
(4-17) p = 0.07 
Male  n (%) 8 (72%) 26 (55 %) 112 (55%) p = 0.07 
Black African Ethnicity n (%) 11 (100%) 45 (96%) 197 (96%) p = 0.07 
Outside Gauteng  n (%) 8 (72%) 36 (77%) 64 (32%) p = 0.13 
Isolated Aortic Stenosis 
Lesion (i.e. no other cardiac 
defects)  
n (%) 4 (36%) 25 (53%) 28 (14%) 
p < 0.05 
Peak Instantaneous Gradient (mmHg)     
Mild PIG (0-20 mmHg) n/N (%) 1/10 (10%) 7/39 (18%) 123/198 (62%)  
Moderate PIG (21-50 mmHg) n/N (%) 5/10 (50%) 16 /39 (41%) 37/198 (19%)  
Severe PIG (> 50 mmHg) n/N (%) 4/10 (40%) 16 /39 (41%) 38/198 (19%) p < 0.05 
Intervention undertaken n (%) 4 (36%) 17 (36%) 119 (58%)  
Balloon valvuloplasty n/N (%) 1/4 (25%) 7/17 (41%) 2/119 (2%)  
Surgical resection n/N (%) 3/4 (75%) 10/17 (59%) 117/119(98%) p < 0.05 
 
Supravalvular Aortic Stenosis 
The  following cardiac defects were the only defects found to co-exist with supravalvular  AS, 
namely; peripheral pulmonary stenosis, right pulmonary artery stenosis and one left pulmonary 
artery stenosis (n=7; 64%). Nine of the 11 (82%) children with supravalvular aortic stenosis 
were confirmed to have Williams Syndrome on chromosomal analysis. The majority (n=7/11; 
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64%) of these were treated conservatively. The four children that underwent surgery had a 
median gradient of 42 mmHg (IQR; 38-57) and no significant PIG was noted between the 
children that underwent surgery and those that did not (Mann-Whitney; p=0.85). None of the 
children experienced a recurrence, and none were found to have infective endocarditis as a 
complication. 
 
Valvular Aortic Stenosis  
Seventeen children (36%) underwent surgery for the valvular lesion and the co-existing cardiac 
defect (coarctation repair 22%, PDA coiling 6% and ASD repair 6%). The median time from 
presentation to surgery was 191 days (IQR; 3-480). Balloon valvuloplasties were performed in 
only seven of the cases (41%), and six were performed after 2004 when balloon interventions 
had become the standard of care for valvular aortic stenosis. Three of the total ten (30%) aortic 
valve replacements were undertaken before 2000. The remainder of the aortic valve surgical 
repairs were carried out during the repair of the co-existing cardiac lesion. Three of the 
seventeen children required a second intervention in the form of an aortic valve replacement, 
2 months, 10 years and 11 years, after the first procedure, which was a balloon valvuloplasty 
in all three cases. 
 
The children that underwent surgery had significantly higher PIGs than those that were treated 
conservatively, median PIG (uncategorised) 51 mmHg (IQR; 48-78) versus median PIG 38 
mmHg (IQR; 32-51) respectively, (Mann-Whitney; p<0.05). The children that had surgery 
were significantly older than those treated conservatively, median age of 72 months (IQR; 0.3-
110) versus 3 months (IQR; 0.1-15) (Mann-Whitney; p<0.05). Approximately 20% died 
immediately after the operation or within the year of follow up. Almost two-thirds (n=29) of 
patients were lost to follow-up. 
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Subvalvular Aortic Stenosis  
The children with SAS (n=205) in the PdA population were made up of 195 (95%) children 
with DSAS, and 10 (5%) with TSAS (Table 3). 
 
None of the TSAS were identified in isolation and the overwhelming majority (n=8; 80%) were 
found to coexist with a ventricular septal defect (Table 3). Amongst the DSAS subgroup, 28 
(15%) were isolated lesions, with more than half (n=101; 52%) co-existing with a ventricular 
septal defect and 39 (20%) with a patent ductus arteriosus. An interesting finding was that there 
were 6 patients with TOF and DSAS. “Other” associations with a DSAS (Table 3) included 
mitral valve disease (n=3); atrial septal defect (n=1); double chamber right ventricle (n=1); 
double outlet right ventricle (n=1); hypoplastic left heart syndrome (n=1); Shone’s complex 
(n=2); single ventricle (n=1); truncus arteriosus (n=2); and total anomalous pulmonary venous 
drainage (n=1). 
 
Table 3: The cardiac defects co-existing with discrete and tunnel-type subvalvular 
stenosis (PdA; 1984 - 2015) 
Type of Subvalvular Stenosis Co-Existing Cardiac Defect Number (n)  (%) 
Tunnel-type SAS (N = 10) Isolated lesion - - 
 Ventricular septal defect 8 (80) 
 Patent ductus arteriosus 1 (10) 
 Coarctation of the aorta 1 (10) 
Discrete SAS (N = 195) Isolated lesion 28 (15) 
 Ventricular septal defect 101 (52) 
 Patent ductus arteriosus 39 (20) 
 Coarctation of the aorta 6 (3) 
 Tetralogy of Fallot 6 (3) 
 Other** 15 (7) 
** Other – listed in text. 
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The majority of patients with SAS (73%) did not have aortic regurgitation (AR) which is a 
well-recognized consequence of this type of AS. Only trivial to mild AR was documented in 
25% of patients with SAS, moreover, less than 2% had moderate AR and less than 1% had 
severe AR. There was no association noted between the severity of the PIG and severity of AR 
(Pearson χ2; p=0.88). 
 
Sixty-one percent of patients with DSAS and 86% of patients with TSAS presented with a mild 
PIG (Figure 1). The majority of patients with DSAS and mild PIG (n=116; 61%) underwent 
surgical intervention. These were usually associated with a ventricular septal defect. However, 
only 70% of children with severe PIG were documented to have had surgery (Figure 1). Two 
of the 23 (9%) children with a PDA and with a severe PIG underwent a PDA ligation, at least 
6 (26%) required a PDA ligation and DSAS resection.   
 
Figure 1: A comparison of peak instantaneous echocardiographic gradients between 
discrete and tunnel-type subvalvular stenosis (PdA 1984 - 2015) 
 
SAS                                
N = 205
DSAS
n = 191
Mild PIG
n = 117 (61%)
Surgery
n = 72 (62%)
Moderate PIG
n = 37 (19%)
Surgery
n = 18 (49%)
Severe PIG
n = 37 (19%)
Surgery
n = 26 (70%)
TSAS
n = 7
Mild PIG
n = 6 (86%)
Surgery
n = 2 (33%)
Moderate PIG
n = 0
Severe PIG
n = 1 (14%)
Surgery
n = 1 (100%)
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Of the children who had surgery, only 25% (n=27) had recurrence of the DSAS requiring repeat 
interventions. None of the patients with TSAS that underwent surgery (n=3) had a recurrence. 
More than two-thirds of patients in the SAS group were lost to follow up. 
 
There was a significant relationship shown between the severities of PIG in DSAS lesions with 
co-existing lesions (Table 4). The majority of children (n=87; 83%) with mild PIGs and DSAS 
presented with ventricular septal defects, whilst only 4% (n=4) had patent ductus arteriosus. In 
contrast, children with severe PIGs were mostly associated with patent ductus arteriosus (n=23; 
66%) (Pearson χ2; p<0.05). 
 
Similarly, the PIG category of patients with TSAS also differed with the co-existing cardiac 
defect; mild gradients were demonstrated with VSDs and coarctation, while severe gradients 
with PDAs, though not significantly (Fisher-exact; p=0.71) (not demonstrated in a table).  
 
Table 4: A comparison of the presenting peak instantaneous gradients of children with 
DSAS and co-existing cardiac defects (PdA; 1984 - 2015) 
Cardiac defect 
occurring with DSAS 
Peak instantaneous gradient category 
Mild 
n (%) 
Moderate 
n (%) 
Severe 
n (%) 
Total 
Ventricular septal defect 87 (83%) 7 (30%) 3 (9%) 97 
Patent ductus arteriosus 4 (4%) 12 (52%) 23 (66%) 39 
Coarctation of the aorta 4 (4%) 2 (9%) 0 - 6 
Tetralogy of Fallot 6 (6%) 0 - 0 - 6 
Other  3 (3%) 2 (9%) 9 (26%) 14 
Total 104 (100%) 23 (100%) 35 (100%) 162 
(Pearson χ2; p < 0.05) 
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Isolated Discrete Subvalvular Stenosis (iDSAS) 
Table 5 expounds on a subset of patients with DSAS that do not have any co-existing cardiac 
defects (n=28). The median age at presentation was slightly but not significantly older, at 36 
months (IQR; 4-59), compared to 17 months (IQR; 4-46) of those with associated cardiac 
defects (aDSAS) (Mann-Whitney; p=0.21). Fifty-seven percent (n=16) of children were male 
(Pearson χ2; p=0.77). 
 
The majority of children with iDSAS presented with mild PIG (n=12; 43%) and moderate PIG 
(n= 14; 50%). Two children (7%) had a severe PIG compared to 21% (n=36) of patients in the 
aDSAS group (Fisher’s exact; p<0.05) (Table 5). 
Table 5: A comparison of demographic and clinical details between children with 
iDSAS and aDSAS (PdA; 1984 - 2015) 
Demographic & Clinical details iDSAS 
(N=28) 
aDSAS 
(N=177) 
p – value 
Age (months) median 
(IQR) 
36 
(4 - 59) 
17 
(4 - 46) p = 0.21 
Male  n (%) 16 (57%) 96 (54%) p = 0.77 
Peak Instantaneous Gradient    
Mild PIG (0-20 mmHg) n/N (%) 12/28 (43%) 111/170 (65%)  
Moderate PIG (21-50 mmHg) n/N (%) 14/28 (50%) 23/170 (14%)  
Severe PIG (> 50 mmHg) n/N (%) 2/28 (7%) 36/170 (21%) p < 0.05 
Aortic Regurgitation is present n/N (%) 15/28 (54%) 41/177 (23%) p < 0.05 
No Recurrence of DSAS n/N (%) 15/19 (79%) 83/106 (78%) p = 0.60 
 
Fifty-four percent (n=15) of iDSAS presented with AR, a significantly higher number than the 
aDSAS group (n=41; 23%) (Pearson χ2; p<0.05). Fourteen children had trivial or mild AR, one 
child had moderate AR and one child had severe AR. A similar percentage of children with 
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iDSAS or aDSAS, experienced a recurrent DSAS lesion, during their follow-up period (Fisher’s 
exact; p=0.60) (Table 5). 
 
Table 6: The types of surgical treatment performed in iDSAS patients according to the 
peak instantaneous gradient category (PdA; 1984 - 2015) 
Peak instantaneous gradient 
category 
Treatment  
Conservative  
n (%) 
DSAS Resection  
n (%) 
Mild PIG (0-20 mmHg) 
6 (50%) 6 (50%) 
Moderate PIG (21-50 mmHg) 
8 (57%) 6 (43%) 
Severe PIG (> 50 mmHg) 
2 (100%) 0 
Total 16 12 
 (Pearson χ2; p = 0.66) 
 
Twelve of the iDSAS (43%) children underwent a DSAS resection (Table 6). Half of the 
patients that underwent surgery required a second operation due to recurrence, detected during 
the follow-up period. There was no noteworthy relationship with PIG category and recurrence 
(Pearson χ2; p=0.26). A large proportion 89% (n=25) were lost to follow-up. 
 
AR remained a significant confounding factor using multivariate analysis (data not shown in 
table) when comparing the iDSAS to the aDSAS group (p < 0.05) and PIG did not remain as a 
significant factor in the model (p=0.38).  
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DISCUSSION 
PdA Population 
Over the study period almost 23 000 children were seen in the Department of Paediatric 
Cardiology, CHBAH and were entered into the database. The most common congenital defects 
identified, were patent ductus arteriosus and ventricular septal defects, in keeping with 
international literature.17 Left ventricular outflow tract obstructive lesions constituted 8% of all 
the congenital cardiac lesions on the database which closely approximates data published from 
other parts of the world.31,32 
 
AS population 
Aortic Stenosis Subtypes 
The most common AS subtype documented in our study population was SAS which is different 
to publications emanating from America, Europe and China, in which, valvular AS was 
reported as the most common subtype.7,8 Supravalvular stenosis was noted as the least common 
subtype in our study, which is congruent with the majority of literature, except those from 
China. 
 
Sex of Aortic Stenosis 
The sex distribution of children with AS is largely male in the literature, however in our 
population boy and girl children were almost equally affected, 1.3:1 compared to 4:1 in the 
international literature.10,32 
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Age of AS diagnosis 
Children in this study cohort presented with AS at a younger age, within their first 2 years of 
life, compared to 6 years in quoted literature.33,34 A possible reason for the younger presentation 
may be the result of its co-existence with serious cardiac defects. The late age of presentation 
has remained a strong postulate for the theory of DSAS development, being an acquired lesion 
rather than congenital. However this was not found to be the case in our population. This could 
possibly highlight the importance of a genetic cause as a disease initiate, or that our population 
group experiences a more rapid progression of disease.  
 
Ethnicity 
The majority of patients seen at the study institution are of black African ethnicity. This may 
support the suggestion of a possible genetic substrate for the younger age at presentation as 
well as the predominance of DSAS as opposed to valvular stenosis as in the western literature. 
This would require further research, as black African children were by far, the most common 
ethnic group seen at CHBAH during the study period and therefore a more varied ethnic study 
group within South African context would be informative. 
 
PIG at presentation 
There existed a statistical significant difference between the PIGs at presentation between the 
different AS subtypes. Children with supravalvular and valvular AS mostly presented with a 
PIG in the moderate to severe categories, while the group with subvalvular AS were mostly 
recorded as having mild PIGs. This again may be attributed to the type of co-existing congenital 
cardiac defect identified in the various subtypes. 
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Subvalvular Stenosis population 
Associated cardiac defects  
Subvalvular stenosis (DSAS and TSAS) in eighty percent of the cases, was associated with 
other cardiac defects compared to only 20-50% reported in the literature.35 The most common 
cardiac lesions in order of frequency were VSDs, PDAs, and coarctation of the aorta. In 
contrast, the most common associated defect reported in the literature is PDAs. Six children 
with TOF were found to have a DSAS, thought to be a rare association first described in 
1976.19,20,36 Changela et al (2010) described that only 1% of patients with TOF were found to 
have a subaortic membrane.20 This emphases the importance of excluding the presence of a 
DSAS in all patients with TOF. 
 
Peak instantaneous gradients 
The majority of children with DSAS and TSAS presented with PIGs in the mild category, 
which is most likely due to a falsely reduced gradient, caused as a result of the decompression 
of pressures proximal to the DSAS in the presence of the VSDs. More patients with a PDA and 
a DSAS were found to have severe gradients, related to increased flow from the left to right 
shunt across the LVOT.37,38 
 
Surgery & Recurrence 
A large proportion of children in the study cohort had surgery to resect their DSAS despite 
mild PIGs, primarily because of the association with co-existing cardiac defects that made 
surgical intervention necessary. This is in contrast with other centres where valvular aortic 
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stenosis is more prevalent and where the majority of interventions are balloon valvuloplasties. 
Surgical treatment is expensive and requires highly trained medical staff which can be a 
prohibitive factor in resource limited settings such as ours. 
 
Furthermore, a lower DSAS recurrence rate of 20% was found in our study population 
compared to a recurrence rate of 30-40% documented in the literature.28,39,40 One postulation 
for the lower recurrence rate is the high numbers lost to follow up.  
 
The analyses of the recurrence group did not show any association with PIG category at 
surgery. However, PIG severity has been shown to predict recurrence in other studies. Perhaps 
the study number may have been too small to show a significant relationship.40,41 
 
Isolated Discrete Subvalvular Stenosis 
Isolated DSAS is a rare subgroup that is not associated with any cardiac defects but may be 
related to subtle anatomical variations of the heart, such as a reduced ventricular aortic angle, 
which is speculated to cause turbulence in the LVOT that results in the formation of  a DSAS.22 
The ventricular-aortic angles were not a standard measurement in this cohort. 
 
Peak instantaneous gradients 
The iDSAS group was not significantly different from the larger aDSAS group, neither by age 
or sex distribution, but the PIGs were higher, falling within the “Moderate PIG” category. In 
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addition, this group was significantly more likely to have aortic regurgitation compared to 
aDSAS. 
 
Surgery & Recurrence 
No relationship was found to exist between recurrence and the PIG category. The lack of an 
association between the PIG and recurrence, may further strengthen the suggestion, which the 
substrate for the development of a DSAS is more likely to be genetic in aetiology, or related to 
the geometry of the LVOTO and that is not correctable surgically. 
 
Follow Up 
A significantly large number of children were lost to follow up. These were patients that 
consecutively missed follow up appointments.  Possible explanations may be medical 
migration back to other provinces or surrounding countries or loss to follow up as a result of 
death.42  
 
LIMITATIONS 
Although most of the patients with AS were captured on the database, the retrospective nature 
of the study and the inevitable problem of missing data from case files reduced the quality of 
the study. It was difficult to verify inaccurate and incomplete information as the study had 
extended over more than two decades. This study methodology does lend itself to these innate 
limitations. The limited parameters collected over the years restricted the uni-, bi- and 
multivariate analyses possible in this study. The large number of children lost to follow up was 
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significant, which made calculating recurrence and evaluating management success less 
accurate.  
 
CONCLUSION 
The study population was comprised of mainly black African children from Soweto, 
neighbouring provinces and adjacent African countries. The profile of AS within the designated 
study group has been shown to be different to that of international literature. DSAS was 
highlighted as the predominant AS subtype at presentation, a small percentage of patients with 
DSAS were identified without cardiac defects. A similar proportion of patients with or without 
cardiac defects experienced DSAS recurrence. Some of these findings may suggest the 
possibility of a genetic or anatomical cause for the development of DSAS. Most of these 
patients required invasive surgical treatment. This study has successfully demonstrated the 
benefit of conducting research to better understand disease profiles in one’s local setting. 
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